Fingerprint
Dive into the research topics of 'Safety and dosing of bevacizumab (Avastin) for the treatment of recurrent respiratory papillomatosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Safety and dosing of bevacizumab (Avastin) for the treatment of recurrent respiratory papillomatosis
Simon R. Best, Aaron D. Friedman, Tali Landau-Zemer, Anca M. Barbu, James A. Burns, Mason W. Freeman, Yuan Di Halvorsen, Robert E. Hillman, Steven M. Zeitels*
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
53
Scopus
citations